Literature DB >> 22277551

Dietary intake of PUFAs and colorectal polyp risk.

Harvey J Murff1, Martha J Shrubsole, Qiuyin Cai, Walter E Smalley, Qi Dai, Ginger L Milne, Reid M Ness, Wei Zheng.   

Abstract

BACKGROUND: Marine-derived n-3 (omega-3) PUFAs may reduce risk of developing colorectal cancer; however, few studies have investigated the association of n-3 PUFA intakes on colorectal polyp risk.
OBJECTIVE: The objective of this study was to examine the associations of dietary PUFA intake on risk of colorectal adenomatous and hyperplastic polyps.
DESIGN: This was a colonoscopy-based case-control study that included 3166 polyp-free control subjects, 1597 adenomatous polyp cases, and 544 hyperplastic polyp cases. Dietary PUFA intake was calculated from food-frequency questionnaires and tested for association by using unconditional logistic regression. The urinary prostaglandin E(2) metabolite, which is a biomarker of prostaglandin E(2) production, was measured in 896 participants by using liquid chromatography and tandem mass spectrometry.
RESULTS: n-6 PUFAs were not associated with adenomatous or hyperplastic polyps in either men or women. Marine-derived n-3 PUFAs were associated with reduced risk of colorectal adenomas in women only, with an adjusted OR of 0.67 (95% CI: 0.47, 0.97) for the highest quintile of intake compared with the lowest quintile of intake (P-trend = 0.01). Dietary intake of α-linolenic acid was associated with an increased risk of hyperplastic polyps in men (P-trend = 0.03), which was not seen in women. In women, but not in men, dietary intake of marine-derived n-3 PUFAs was negatively correlated with urinary prostaglandin E(2) production (r = -0.18; P = 0.002).
CONCLUSION: Higher intakes of marine-derived n-3 PUFAs are associated with lower risk of adenomatous polyps in women, and the association may be mediated in part through a reduction in the production of prostaglandin E(2). This trial was registered at clinicaltrials.gov as NCT00625066.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22277551      PMCID: PMC3278245          DOI: 10.3945/ajcn.111.024000

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  57 in total

1.  Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice.

Authors:  Melissa B Hansen-Petrik; Michael F McEntee; Brian Jull; Hang Shi; Michael B Zemel; Jay Whelan
Journal:  Cancer Res       Date:  2002-01-15       Impact factor: 12.701

Review 2.  Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

Authors:  R A Gupta; R N Dubois
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

Review 3.  Polyunsaturated fatty acids in the food chain in the United States.

Authors:  P M Kris-Etherton; D S Taylor; S Yu-Poth; P Huth; K Moriarty; V Fishell; R L Hargrove; G Zhao; T D Etherton
Journal:  Am J Clin Nutr       Date:  2000-01       Impact factor: 7.045

4.  Antagonism of arachidonic acid is linked to the antitumorigenic effect of dietary eicosapentaenoic acid in Apc(Min/+) mice.

Authors:  M B Petrik; M F McEntee; C H Chiu; J Whelan
Journal:  J Nutr       Date:  2000-05       Impact factor: 4.798

Review 5.  Dietary modification of inflammation with lipids.

Authors:  Philip C Calder
Journal:  Proc Nutr Soc       Date:  2002-08       Impact factor: 6.297

6.  Cox-2 expression, PGE(2) and cytokines production are inhibited by endogenously synthesized n-3 PUFAs in inflamed colon of fat-1 mice.

Authors:  Claudia Gravaghi; Krista M D La Perle; Paul Ogrodwski; Jing X Kang; Fred Quimby; Martin Lipkin; Sergio A Lamprecht
Journal:  J Nutr Biochem       Date:  2010-07-23       Impact factor: 6.048

7.  Comparison of cyclo-oxygenase 2 expression in colorectal serrated adenomas to expression in tubular adenomas and hyperplastic polyps.

Authors:  Manabu Takeuchi; Masaaki Kobayashi; Yoichi Ajioka; Terasu Honma; Yutaka Suzuki; Masaki Azumaya; Rintarou Narisawa; Syun-ichi Hayashi; Hitoshi Asakura
Journal:  Int J Colorectal Dis       Date:  2002-05       Impact factor: 2.571

8.  Highly unsaturated (n-3) fatty acids, but not alpha-linolenic, conjugated linoleic or gamma-linolenic acids, reduce tumorigenesis in Apc(Min/+) mice.

Authors:  M B Petrik; M F McEntee; B T Johnson; M G Obukowicz; J Whelan
Journal:  J Nutr       Date:  2000-10       Impact factor: 4.798

9.  Effect of low-to-moderate amounts of dietary fish oil on neutrophil lipid composition and function.

Authors:  D A Healy; F A Wallace; E A Miles; P C Calder; P Newsholm
Journal:  Lipids       Date:  2000-07       Impact factor: 1.880

10.  Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men*.

Authors:  Graham C Burdge; Amanda E Jones; Stephen A Wootton
Journal:  Br J Nutr       Date:  2002-10       Impact factor: 3.718

View more
  21 in total

Review 1.  Nutrient-Gene Interaction in Colon Cancer, from the Membrane to Cellular Physiology.

Authors:  Tim Y Hou; Laurie A Davidson; Eunjoo Kim; Yang-Yi Fan; Natividad R Fuentes; Karen Triff; Robert S Chapkin
Journal:  Annu Rev Nutr       Date:  2016-07-17       Impact factor: 11.848

Review 2.  Prostaglandin E3 metabolism and cancer.

Authors:  Peiying Yang; Yan Jiang; Susan M Fischer
Journal:  Cancer Lett       Date:  2014-03-18       Impact factor: 8.679

3.  Potential of Omega-3 Polyunsaturated Fatty Acids in Managing Chemotherapy- or Radiotherapy-Related Intestinal Microbial Dysbiosis.

Authors:  Yue Zhang; Boyan Zhang; Lihua Dong; Pengyu Chang
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

4.  PUFA levels in erythrocyte membrane phospholipids are differentially associated with colorectal adenoma risk.

Authors:  Samara B Rifkin; Martha J Shrubsole; Qiuyin Cai; Walter E Smalley; Reid M Ness; Larry L Swift; Wei Zheng; Harvey J Murff
Journal:  Br J Nutr       Date:  2017-06-29       Impact factor: 3.718

Review 5.  Immune regulation and anti-cancer activity by lipid inflammatory mediators.

Authors:  Saraswoti Khadge; John Graham Sharp; Timothy R McGuire; Geoffrey M Thiele; Paul Black; Concetta DiRusso; Leah Cook; Lynell W Klassen; James E Talmadge
Journal:  Int Immunopharmacol       Date:  2018-11-14       Impact factor: 4.932

Review 6.  ω-3 polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer.

Authors:  Weicang Wang; Julia Zhu; Fei Lyu; Dipak Panigrahy; Katherine W Ferrara; Bruce Hammock; Guodong Zhang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-07-11       Impact factor: 3.072

7.  ω-3 Polyunsaturated fatty acids and their cytochrome P450-derived metabolites suppress colorectal tumor development in mice.

Authors:  Weicang Wang; Jun Yang; Yoshiki Nimiya; Kin Sing Stephen Lee; Katherine Sanidad; Weipeng Qi; Elvira Sukamtoh; Yeonhwa Park; Zhenhua Liu; Guodong Zhang
Journal:  J Nutr Biochem       Date:  2017-06-21       Impact factor: 6.048

8.  Dietary intake of fish, ω-3 and ω-6 fatty acids and risk of colorectal cancer: A prospective study in U.S. men and women.

Authors:  Mingyang Song; Andrew T Chan; Charles S Fuchs; Shuji Ogino; Frank B Hu; Dariush Mozaffarian; Jing Ma; Walter C Willett; Edward L Giovannucci; Kana Wu
Journal:  Int J Cancer       Date:  2014-04-15       Impact factor: 7.396

9.  A prospective study of erythrocyte polyunsaturated fatty acids and risk of colorectal serrated polyps and conventional adenomas.

Authors:  Liang Wang; Dong Hang; Xiaosheng He; Chun-Han Lo; Kana Wu; Andrew T Chan; Shuji Ogino; Edward L Giovannucci; Mingyang Song
Journal:  Int J Cancer       Date:  2020-08-05       Impact factor: 7.396

10.  Assessing the safety of transarterial locoregional delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat liver.

Authors:  Junjie Li; Diana Canseco; Yuzhu Wang; Gonçalo Vale; Jaideep Chaudhary; Arnida Anwar; Hamid Baniasadi; Noelle S Williams; Purva Gopal; Patrick D Sutphin; Jeffrey G McDonald; William C Putnam; Ian R Corbin
Journal:  Eur J Pharm Biopharm       Date:  2020-11-24       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.